Synageva BioPharma To Present At The Cowen and Company Health Care Conference

LEXINGTON, Mass., Feb. 25, 2015 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, announced today its presentation at the upcoming Cowen and Company 35th Annual Health Care Conference in Boston, MA.

Sanj K. Patel, President and Chief Executive Officer of Synageva, will present on Tuesday, March 3, 2015, at 8:00 a.m. EST.  The presentation will be webcast live and may be accessed from the Investor Relations section of Synageva's website at www.synageva.com.

Synageva routinely posts information that may be important to investors in the Investor Relations section of the company's website at www.synageva.com. Synageva encourages investors and potential investors to consult this website regularly for important information about the company.

Further information regarding Synageva is available at www.synageva.com.

"Synageva BioPharma™" is a trademark, and "Dedicated to Rare Diseases®" is a registered trademark, of Synageva BioPharma Corp. 

Logo - http://photos.prnewswire.com/prnh/20140522/90728

SOURCE Synageva BioPharma Corp.

Related Links

http://www.synageva.com